PBCAR-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PBCAR-T, covering 2025-05-14 to 2025-05-14. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study